The Longevity Podcast: Alzheimer's and Brain Health Research
AI-hosted deep dives into the latest Alzheimer's, dementia and brain health research, curated by Dr. Dung Trinh. Each episode breaks down a recent study or topic, such as diet, sleep, exercise, heart health, biomarkers, early detection and new treatments. We explain what the science says and what it may mean for staying sharp as we age.
Episodes are discussions generated with AI hosts. Every episode cites its sources so you can read the original research yourself. This podcast is for education only and is not medical advice. Talk with your doctor about your own health.
The Longevity Podcast: Alzheimer's and Brain Health Research
Brain Health: Does High-Dose DHA From Fish Oil Reach the Aging Brain?
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In a two-year randomized, double-blind, placebo-controlled trial, 365 adults aged 55 to 80 at higher risk for dementia took 2,000 mg of DHA, an omega-3 fatty acid found in fish oil, or a placebo each day. DHA levels in the fluid around the brain rose by about 17%, but the trial found no benefit to memory or thinking. We look at what the study measured, what it found, and its limitations, including that about 38% of participants dropped out. This episode is for education only and is not medical advice.
Source: Yassine HN et al. "CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial." eBioMedicine 2026;129:106316. https://doi.org/10.1016/j.ebiom.2026.106316 (CC BY 4.0)
This podcast is created by Ai for educational and entertainment purposes only and does not constitute professional medical or health advice. Please talk to your healthcare team for medical advice.
Never miss an episode—subscribe on your favorite podcast app!
The Supplement Paradox
SPEAKER_02So uh what if I told you that scientists finally proved, like with one hundred percent certainty, that taking a high dose brain supplement successfully gets that nutrient directly into your central nervous system.
SPEAKER_00Right.
SPEAKER_02But then uh they realize that it completely failed to improve memory anyway.
SPEAKER_00Yeah, it's uh is really one of the most revealing paradoxes in recent neuroscience, honestly.
SPEAKER_02It's wild. Today we are looking at a massive new study that reveals why getting a vitamin into your head might just mean you're you know feeding it directly into a microscopic wood chipper.
SPEAKER_00Aaron Powell Exactly. I mean, we have spent decades trying to force nutrients across the blood-brain barrier. We always just assumed that uh delivery equals treatment.
SPEAKER_01Right.
SPEAKER_02Like if it gets there, it works.
SPEAKER_00Aaron Powell Exactly. But this study completely shatters that assumption.
SPEAKER_02Aaron Powell Which is exactly why we are doing a deep dive into it today. Because if you are well, really anyone who wants to stay sharp as you age, you have probably stood in the supplement aisle staring at a wall of vitamins, wondering if any of them actually do anything.
SPEAKER_00Oh, absolutely. It's overwhelming.
SPEAKER_02Totally. So our mission today is to unpack this really fascinating recently published 24-month study. It looks specifically at high dose omega-3 supplementation, uh, specifically DHA, and its effect on brain health.
SPEAKER_00That's a huge one.
SPEAKER_02It is. But before we dive into the deep end, I do need to give our mandatory disclaimer.
SPEAKER_00Always important.
SPEAKER_02Yeah. This deep dive is strictly for educational purposes, guys. It is not medical advice. We are absolutely not going to give you any personal opinions or advice on whether you, the listener, should be taking supplements.
SPEAKER_00Right. No medical advice here. Trevor Burrus, Jr.
SPEAKER_02And we are not naming any brands, we're not pushing any products, and we actually aren't even naming the specific trials. We are just here to look at the data.
SPEAKER_00Aaron Powell And we desperately need to look at this data because for a long time the scientific answers around brain supplements have been, well, incredibly frustrating.
SPEAKER_01Muddy.
SPEAKER_00Exactly.
SPEAKER_01Very muddy.
SPEAKER_00The research on omega-3s has been the absolute definition of diagnostic muddy waters.
Why Omega-3 Evidence Conflicts
SPEAKER_02Aaron Powell, let's actually start right there with the mud. Because as an outside observer, it feels like, I don't know, every six months there is a new headline.
SPEAKER_00Oh, for sure.
SPEAKER_02Like one day fish oil is a miracle cure for dementia, the next day it's just expensive snake oil. Why is the historical data so all over the place?
SPEAKER_00Aaron Powell Well, it comes down to the difference between observing populations and running controlled clinical trials. Aaron Powell Okay.
SPEAKER_01How so?
SPEAKER_00So in observational studies, researchers might look at, say, thousands of people and notice that those who eat a lot of fatty fish tend to have great brain volume.
SPEAKER_02Right.
SPEAKER_00And they have lower rates of dementia later in life.
SPEAKER_02Aaron Powell Which makes logical sense. So they see that correlation and they assume the omega-3s in the fish are the hero.
SPEAKER_00Aaron Powell That is the assumption, yeah. But then researchers try to replicate that in a clinical trial. They take a group of people, give half of them an omega-3 pill, give the other half a placebo, and they wait.
SPEAKER_02Aaron Ross Powell And nothing happens.
SPEAKER_00Aaron Ross Powell Historically, yes. Those clinical trials have shown completely null results, like zero benefit. So the scientific community has just been stuck asking, you know, are the observational studies wrong? Is there some other lifestyle factor protecting the fish eaters? Or are our clinical trials just fundamentally flawed?
SPEAKER_02Aaron Powell Okay, let's unpack this.
Fixing Past Trial Design Flaws
SPEAKER_02Because if previous trials of omega-3s, especially in Alzheimer's patients, showed completely null results, why would these researchers even bother?
SPEAKER_00Right.
SPEAKER_02I mean, spending the time and millions of dollars doing another massive 24-month study, it feels like uh trying to squeeze water from a stone.
SPEAKER_00Aaron Powell It does. Aaron Powell But there is a growing realization that earlier clinical studies might have been setting themselves up to fail, basically based on their design.
SPEAKER_02Aaron Powell How did they fail?
SPEAKER_00Aaron Powell Well, past trials typically made two major missteps. First, they gave really low doses. We are talking often one gram or less per day.
SPEAKER_02Aaron Powell So just like throwing a thimble of water onto a raging house fire.
SPEAKER_00Aaron Powell That is a very apt way to put it, yeah. And second, they often tested these low dose supplements on people who already had established Alzheimer's dementia.
SPEAKER_02Aaron Powell Uh, I see.
SPEAKER_00Yeah.
SPEAKER_02Aaron Ross Powell So it's like waiting until the highway is already completely broken up, riddled with massive potholes and structural damage, and then sending in one guy with a bucket of asphalt to try and fix the entire interstate.
SPEAKER_00Aaron Powell Precisely, because by the time Alzheimer's dementia is clinically established, there is already significant widespread neuronal loss. Right. So this new study wanted to completely flip the script. They wanted to test the concept of prevention, or at least, you know, very early intervention. Okay. So they tested a high dose, two full grams of DHA a day.
Who Qualified And Why APOE-4
SPEAKER_00And they specifically targeted people without dementia.
SPEAKER_02Aaron Powell So who exactly were they testing this on? Because, you know, you can't just grab anyone off the street if you want clean data. Like if I'm already eating salmon three times a week, my tank is full.
SPEAKER_00Right, exactly.
SPEAKER_02Giving me a supplement isn't going to show you what the supplement can do.
SPEAKER_00Aaron Powell You hit the nail on the head regarding the inclusion criteria there. They recruited 365 older adults, ranging in age from 55 to 80.
SPEAKER_02Okay, so older demographic.
SPEAKER_00Yes. And to get into the study, you had to have normal cognition, meaning absolutely no dementia. And crucially, you had to have a low dietary intake of omega-3s.
SPEAKER_01Aaron Powell Like how low?
SPEAKER_00We are talking less than 200 milligrams a day. They wanted people whose tanks were definitively running low.
SPEAKER_02Aaron Powell Okay. So older adults cognitively healthy but lacking the nutrient in their daily diet. Was that the only hurdle to get into the study?
SPEAKER_00You'd think so, but no. The researchers added one more hurdle to make sure they were testing a truly vulnerable population. The participants had to have at least one risk factor for dementia.
SPEAKER_01Aaron Powell What kind of risk factor?
SPEAKER_00This could be a lifestyle factor like obesity or vascular issues like hypertension, or even just physical inactivity.
SPEAKER_02Aaron Powell Which they defined as what?
SPEAKER_00Exercising less than three days a week.
SPEAKER_02Okay, got it. But there was also a genetic component to this, right? The uh the APOE gene. I feel like I see this mentioned constantly when we talk about Alzheimer's risk.
SPEAKER_00Aaron Powell Yes, the APOE epsilon-4 allele. This is a really vital piece of the puzzle. Apoe epsilon-4 is currently the strongest known genetic risk factor for late-onset Alzheimer's disease. Okay. But what is really fascinating for this specific study is how this gene interacts with omega-3 fatty acids.
SPEAKER_02Aaron Ross Powell How so? Do they clash?
SPEAKER_00Essentially, yes. People who carry the ApoE Epsilon-4 gene tend to break down DHA much faster than non-carriers.
SPEAKER_01Oh, wow.
SPEAKER_00Yeah, it drives accelerated DHA catabolism. Their bodies just chew through the nutrient at a much higher rate.
SPEAKER_02Aaron Powell Wait, so if the gene acts like a furnace that just burns up the DHA before it can do any good, why even try giving them the supplement?
SPEAKER_00Aaron Powell That's a big question.
SPEAKER_02Doesn't that mean they are just a lost cause for this kind of intervention?
SPEAKER_00Aaron Powell That was exactly the primary mystery the researchers wanted to solve. They really wanted to know if we give a truly massive dose of DHA, like those two grams a day, can we overwhelm that genetic furnace?
SPEAKER_01Oh, I see.
SPEAKER_00Does the ApoEpsilon4 gene act like an absolute roadblock, preventing the brain from even absorbing this supplement? Or can we just force the delivery through sheer volume?
SPEAKER_02Aaron Powell Which brings us to how they actually measured this delivery.
Proving Delivery Past The Barrier
SPEAKER_02Because I think a lot of people just assume that if you swallow a pill, it goes into your stomach, enters your bloodstream, and just, I don't know, washes over your brain.
SPEAKER_00Right, like it's a direct pipeline.
SPEAKER_02Exactly. But the brain doesn't work like that. It is protected by the blood brain barrier.
SPEAKER_00It is a notoriously formidable fortress. The blood brain barrier is this highly selective, semi-permeable border of endothelial cells.
SPEAKER_01Okay.
SPEAKER_00It's designed to let essential nutrients in, but keep pathogens and toxins circulating in the blood out.
SPEAKER_02Which is good.
SPEAKER_00Usually, yes, but it makes it very, very difficult to know for sure if a dietary supplement is actually crossing that barrier and entering the central nervous system. Blood tests alone cannot tell you what is happening inside the brain.
SPEAKER_02Aaron Powell So how did they prove it?
SPEAKER_00Well, this is where the study design gets incredibly rigorous and honestly a bit intense for the participants. Uh oh. A large portion of these older adults bravely agreed to undergo lumbar punctures.
SPEAKER_02Wait, spinal taps?
SPEAKER_00Yes.
SPEAKER_02Oh my gosh.
SPEAKER_00At the beginning of the study and then again at the six-month mark.
SPEAKER_02Aaron Powell I just want to pause and acknowledge that for a second. That is serious dedication to science from those participants.
SPEAKER_00Truly.
SPEAKER_02Like a lumbar puncture is not just a quick blood draw at the clinic. They are inserting a needle into the lower spinal canal to extract fluid. That is a physically demanding thing to volunteer for.
SPEAKER_00It is a major commitment. But it was the only way to get the golden ticket of data. They needed to test the cerebrospinal fluid.
SPEAKER_02Aaron Powell The clear liquid that actually bathed the brain to the spinal cord.
SPEAKER_00Exactly. Because by measuring the nutrient levels in that specific fluid, they could prove definitively, without a shadow of a doubt, whether the DHA was actually crossing the blood-brain barrier.
SPEAKER_02Trevor Burrus, it is like ordering an incredibly important package online and constantly checking the tracking.
SPEAKER_00Yeah.
SPEAKER_02Past studies didn't know if the package got lost in the mail somewhere between the digestive tract and the central nervous system. But here, by tapping into the spinal fluid, they were going to get the actual physical delivery signature.
SPEAKER_00Aaron Powell And at the six-month mark, they checked those signatures. And it was a massive, undeniable biochemical win.
SPEAKER_02Yes.
SPEAKER_00Yes.
SPEAKER_02The package arrived.
SPEAKER_00It arrived, and it was signed for. The high dose supplement robustly increased the DHA to arachidonic acid ratio in the spinal fluid by 17% compared to the placebo group.
SPEAKER_02Wait, hold on. Arachidonic acid. What is that and why do we care about a ratio? Didn't we just want to see if the raw DHA levels went up?
SPEAKER_00That is a great question because the ratio is actually more important than the raw number here. Why? Arachidonic acid is another type of fatty acid, an omega-6, and it is highly associated with promoting inflammation in the body and the brain. DHA, on the other hand, is generally anti-inflammatory.
SPEAKER_01Okay. So they compete.
SPEAKER_00Basically, yeah. So by measuring the ratio between the two, the researchers aren't just seeing if the DHA arrived in the fluid. They are seeing if it successfully tipped the biochemical scales in the brain away from an inflammatory state and toward a healthier anti-inflammatory state.
SPEAKER_02Aaron Powell And a 17% shift in that ratio, that is highly significant.
SPEAKER_00Very significant.
SPEAKER_02Okay, that makes total sense. You want to see the good guys outnumber the bad guys, but what about the people with that genetic risk factor, the APOE epsilon-4 carriers?
SPEAKER_00Right.
SPEAKER_02Did their genetic furnace just burn up the delivery?
SPEAKER_00Aaron Powell That was actually the most triumphant part of the six-month data. The supplement worked on a biochemical level regardless of whether the person carried the APOE epsilon-4 gene.
SPEAKER_01Oh wow.
SPEAKER_00The delivery system functioned perfectly for everyone. The researchers proved that if you give a high enough dose, you can force that nutrient into the central nervous system, completely bypassing that genetic roadblock.
SPEAKER_02Okay, we did it. We cracked the code. We got the delivery signature. The brain is bathed in this anti-inflammatory nutrient. That means over the next year and a half of the study, their memory improved, their brain stopped shrinking, and they lived happily ever after, right?
When Delivery Produces Zero Benefit
SPEAKER_00Aaron Powell Well, this is where we have to look at the 24-month reality check. And I have to warn you, it is a sobering reality check.
SPEAKER_02Uh-oh. I am bracing myself.
SPEAKER_00Despite that confirmed robust biochemical delivery at six months, over the full 24 months of the trial, there was absolutely zero difference in cognitive performance between the group taking the high dose DHA and the group taking the placebo pill.
SPEAKER_02Hold on, hold on. Zero difference?
SPEAKER_00None.
SPEAKER_02None at all. But we just established that DHA is physically in their spinal fluid. It shifted the inflammatory ratio. It has to be doing something. Are you sure they didn't just use the wrong cognitive tests to measure the improvement?
SPEAKER_00The researchers used an incredibly comprehensive battery of validated neuropsychological tests. They measured memory, executive function, processing speed.
SPEAKER_01And nothing.
SPEAKER_00The data is clear. There was no clinical benefit. And it wasn't just pen and paper cognitive test scores either. They also use advanced neuroimaging.
SPEAKER_01Like MRIs?
SPEAKER_00Yeah. They perform deep learning segmentation on MRI scans to look at the physical volume of the brain.
SPEAKER_01Aaron Powell Deep Learning segmentation? That sounds intense.
SPEAKER_00Aaron Powell They used artificial intelligence to analyze the MRI images down to the millimeter, specifically looking at the hippocampus.
SPEAKER_01The memory center.
SPEAKER_00Exactly. That is the memory center of the brain, and it is the region that notoriously shrinks as Alzheimer's disease progresses. They wanted to see if the DHA preserved the physical structure of the brain.
SPEAKER_02Aaron Ross Powell And did the supplement group have more brain volume after two years?
SPEAKER_00There was no significant difference in brain structure between the two groups.
SPEAKER_02Aaron Powell Wait, how is that possible? Both groups just what stayed exactly the same?
SPEAKER_00Essentially, yes. Both groups saw very minimal brain shrinkage, which is perfectly normal for that age range. And paradoxically, both groups actually saw slight improvements in their cognitive test scores.
SPEAKER_02Aaron Powell Wait, how does the placebo group improve their memory? They were taking a fake pill.
SPEAKER_00Aaron Powell It is what we call a practice effect.
SPEAKER_02Oh, sure.
SPEAKER_00Trevor Burrus It's like taking the SATs multiple times. Even if you don't actually get smarter, you get better at the mechanics of taking the test itself.
SPEAKER_02Aaron Ross Powell Right. The participants just got used to the cognitive assessments.
SPEAKER_00Aaron Ross Powell Exactly. The critical finding is that the massive doses of DHA provided no added benefit over a placebo.
SPEAKER_02Aaron Powell But the delivery was successful. We have the spinal fluid signature. Why would putting the necessary nutrient right where the brain needs it do absolutely
The Enzyme Wood Chipper Theory
SPEAKER_02nothing?
SPEAKER_00Aaron Ross Powell Because delivering a nutrient to the brain is not enough if the brain cannot use it properly once it gets there. And this teaches us a fundamental lesson about the complexity of human biology.
SPEAKER_02Aaron Powell So it's like delivering high-quality lumber to a construction site, but instead of building a house, a rogue crew immediately throws all the wood into a woodchepper.
SPEAKER_00Aaron Ross Powell That is a remarkably accurate analogy. The researchers suggest that pathological enzymes in the brain might be acting exactly like that rogue crew.
SPEAKER_02Aaron Ross Powell Enzymes?
SPEAKER_00Yeah. There is an enzyme called calcium-dependent phospholipase A2, or CPLA2 for short.
SPEAKER_02Okay. CPLA2.
SPEAKER_00In an aging brain, or more importantly, a brain experiencing inflammation, this specific enzyme can become highly hyperactive.
SPEAKER_02So the wood chipper gets turned on. But how? What flips the switch?
SPEAKER_00Aaron Ross Powell Well, this is where we connect the brain to the rest of the body. When you have hypertension, for example, the high blood pressure puts mechanical stress on your blood vessels. Right. That physical stress creates systemic inflammation throughout your body. Those inflammatory markers travel through your bloodstream, eventually cross the blood-brain barrier, and basically act as the chemical alarm bell that wakes up that CPLA2 wood chipper enzyme.
SPEAKER_02Wow. Okay, so when the DHA arrives at the cellular level, right at the synaptic membranes where it's desperately needed to build and repair memory networks, this activated enzyme just attacks it.
SPEAKER_00Exactly. It immediately breaks the DHA down and alters its fate. It catabolizes the polyunsaturated fatty acids before they can actually be incorporated into the physical structure of the brain.
SPEAKER_02Aaron Powell So we successfully ship the package, but the moment it was open on site, it was destroyed by an inflamed environment.
SPEAKER_00Yeah.
SPEAKER_02That is incredibly frustrating, but also really illuminating.
SPEAKER_00It completely redirects the entire field of research. It tells us that we can't just keep escalating the dose of a supplement and expecting a different clinical result. The problem isn't the delivery truck anymore. The problem is the toxic environment on the construction site itself.
SPEAKER_02So the environment in the brain was hostile. But wait, if they tracked these folks for two years, do the researchers actually measure their baseline inflammation to prove this hostile environment theory?
COVID Dropouts And Trial Bias
SPEAKER_00And that brings us to one of the major limitations of how this trial played out in reality, because, you know, no clinical trial exists in a vacuum. Right. And we have to address this to ensure a balanced view of the data. The most significant limitation of this study was a massive 38% dropout rate.
SPEAKER_0238%. Almost four out of 10 people just left.
SPEAKER_00Yep.
SPEAKER_02That is a huge chunk of data, completely gone. What happened?
SPEAKER_00The COVID-19 pandemic.
SPEAKER_02Oh.
SPEAKER_00Yeah, this trial ran from 2018 to 2024. Right in the middle of it, the entire world shut down. Older adults understandably did not want to risk coming into a hospital facility for hours of cognitive testing or invasive lumbar punctures during a severe respiratory pandemic.
SPEAKER_02Aaron Powell, which completely makes sense for their personal safety, but it has to be a nightmare for the statisticians trying to analyze the trial at the end.
SPEAKER_00Aaron Powell Oh, it is a profound loss of data that can introduce a major bias into the results. Because dropouts are rarely random.
SPEAKER_02Aaron Powell What do you mean?
SPEAKER_00The researchers noted that the people who dropped out tended to have slightly lower education levels and lower baseline cognitive scores at the start of the study.
SPEAKER_02Aaron Powell Meaning the people who were perhaps most vulnerable to decline were the ones who left.
SPEAKER_00Aaron Ross Powell Exactly. So the people who stayed in the trial to the bitter end, the surviving cohort, were generally speaking very healthy, highly educated, and showed almost no cognitive decline to begin with.
unknownAh.
SPEAKER_02So if they weren't really declining in the first place, it's incredibly hard for a two-year study to measure a like a saving effect. Aaron Powell Right. Trevor Burrus, you can't prove the repaving truck works if there aren't any potholes on the road yet.
SPEAKER_00Trevor Burrus Precisely. Two years might simply not be a long enough window to see a clinical difference in a group of relatively healthy, highly educated adults in their 60s.
SPEAKER_02Aaron Powell But they weren't perfectly healthy, right? We established at the beginning they had to have at least one risk factor to even qualify.
SPEAKER_00And this brings us to what might be the most crucial actionable takeaway from the entire study.
Why Lifestyle Beats A Magic Pill
SPEAKER_00Let's look at the lifestyle reality of this participant pool.
SPEAKER_01Okay.
SPEAKER_0069% of them reported exercising less than three days a week. Nearly 40% were obese. Over 50% had hypertension.
SPEAKER_02So what does this all actually mean for the listener? Like if I'm sitting here thinking about my own brain health, what is the profound so what of all this data?
SPEAKER_00Aaron Powell The so what is a complete paradigm shift in how we view brain health. You cannot out-supplement a sedentary lifestyle or systemically inflamed body. Right. The idea of single nutrient supplements acting as monotherapies, meaning a magic bullet pill that you take in isolation to fix complex aging, is highly likely to be a failed strategy.
SPEAKER_02Aaron Powell So the takeaway here isn't just a generic public service announcement that exercise is good for you. It's that cardiovascular exercise and blood pressure management are the literal biological prerequisites required for your expensive supplements to actually work.
SPEAKER_00That is the exact revelation.
SPEAKER_02If you have unmanaged hypertension and you aren't moving your body, you are creating an inflammatory state. You are activating those rogue enzymes.
SPEAKER_00You are leaving the wood chipper turned on.
SPEAKER_02Yes.
SPEAKER_00So even if you spend a fortune on a high-quality DHA supplement, and even if it successfully crosses the blood-brain barrier, your brain is trapped in an environment where it cannot utilize the nutrient.
SPEAKER_02We really have to stop viewing the brain as an isolated organ that we can just drop a pill into and start viewing it as an integrated part of the entire body's ecosystem.
SPEAKER_00It is the only way forward. The researchers themselves concluded that future studies shouldn't just be about conducting more simple supplementation trials. Right. The focus has to shift to understanding the metabolism of the brain, like how it actually processes and utilizes these nutrients in real time under different biological conditions and lifestyle interventions.
SPEAKER_02So to summarize our deep dive today, this landmark 24-month study proved definitively that a high dose of DHA, two grams a day, can and does successfully cross the blood-brain barrier and reach the brain.
SPEAKER_00Yes.
SPEAKER_02Even in people who were genetically at risk with the APOE epsilon-4 gene, the package arrives safely.
SPEAKER_00The biochemical delivery was an absolute proven success.
SPEAKER_02But, and it is a massive but. Getting the nutrient into the central nervous system doesn't automatically preserve cognitive function or stop the brain's memory centers from shrinking over a two-year period.
SPEAKER_00Sadly, no.
SPEAKER_02If the body is inflamed from physical inactivity or vascular issues like high blood pressure, the brain's enzymes might just be destroying the delivery the second it arrives.
SPEAKER_00Which raises a really thrilling question about where the science
The Gut Microbiome Next Frontier
SPEAKER_00goes next. And I want to leave you, the listener, with a final concept to mull over that the researchers briefly touched upon in their conclusions. Where do we look if the brain is destroying its own medicine? Aaron Powell Well, when we talk about inflammation and processing nutrients and how the body fundamentally decides what to do with a supplement, we might be looking at the wrong organ entirely.
SPEAKER_01Really?
SPEAKER_00Yeah. Future studies are likely going to look heavily at the gut microbiome to identify who actually benefits from these interventions.
SPEAKER_01Wait, the gut?
SPEAKER_00Yes. The gut brain axis. There is a massive superhighway of communication, primarily the vagus nerve, linking your intestinal tract directly to your brain.
SPEAKER_01Okay.
SPEAKER_00What if the deciding factor for your brain's health isn't actually in your head at all, but rather dictated by the specific colonies of bacteria living in your stomach?
SPEAKER_01Oh wow.
SPEAKER_00What if the key to unlocking a supplement's power, the secret to reaching up and turning off that wood chipper enzyme in the brain, is first cultivating the right microbial environment in your gut?
SPEAKER_01That makes a lot of sense.
SPEAKER_00Because those billions of bacteria are the ones actually regulating your systemic inflammation and baseline metabolism.
SPEAKER_02That is wild.
SPEAKER_00So going back to our highway analogy, maybe the repaving truck is physically dispatched to the brain, but the traffic control center calling the shots, the dispatcher deciding if the road actually gets fixed, is located in your stomach.
SPEAKER_02It is an entirely new frontier of neuroscience. And it shows just how miraculously interconnected we really are. We are not a collection of isolated parts. We are a complex single ecosystem. Well, that is definitely something profound to chew on next time you are standing in the supplement aisle.
Bigger Picture Closing Thoughts
SPEAKER_02Thank you for joining us on this deep dive. Keep questioning the simple answers. Keep learning about how your incredible body works. And always remember to look at the bigger picture. We'll catch you next time.